Web Event: Rx Drugs and the U.S. Health System – A Conversation about Election-Cycle Proposals for Lowering Costs
This election cycle, policymakers and politicians are weighing in with ideas for lowering drug costs, from permitting Medicare to negotiate prices to allowing consumers to import medicines from other countries.
On Wednesday, October 5, the Kaiser Family Foundation hosted a web conversation to discuss proposals for controlling prescription drug costs, examine pros and cons of the ideas, and assess the likelihood that the plans will be enacted.
Larry Levitt, senior vice president for special initiatives and co-executive director of the Foundation’s Program for the Study of Health Reform and Private Insurance, moderated the discussion with panelists:
- Gerard Anderson, professor, Johns Hopkins Bloomberg School of Public Health
- Jennifer Bryant, senior vice president of policy and research, Pharmaceutical Research and Manufacturers of America
- Dana Goldman, Leonard D. Schaeffer Chair and Director of the USC Schaeffer Center for Health Policy and Economics
Rx Drugs and the U.S. Health System is a series of web panel discussions hosted by the Kaiser Family Foundation exploring prescription drug costs and spending in the U.S. health system.